Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
71,764,033
-
Share change
-
-1,709,833
-
Total reported value
-
$26,345,990,159
-
Put/Call ratio
-
91%
-
Price per share
-
$367.09
-
Number of holders
-
570
-
Value change
-
-$641,633,351
-
Number of buys
-
270
-
Number of sells
-
232
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2016
As of 31 Dec 2016,
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) was held by
570 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,764,033 shares.
The largest 10 holders included
FMR LLC, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, STATE STREET CORP, BlackRock Fund Advisors, SANDS CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., JENNISON ASSOCIATES LLC, and Artisan Partners Limited Partnership.
This page lists
570
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.